Test Price
2,800 AED✅ Home Collection Available
SMARCB1 Gene Genetic Test for Intellectual Disability (Autosomal Dominant Type 15) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SMARCB1 للإعاقة الذهنية الوراثية السائدة نوع 15 NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Your Trusted Genetic Diagnosis Partner
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-accredited NGS processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection, with VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation from our expert panel.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: فحص جيني معتمد بدقة 99.9% عبر تقنية NGS لجين SMARCB1، مع خدمة منزلية متميزة واستشارة طبية متخصصة بعد النتيجة.
Overview – Superior Molecular Precision for Neurodevelopmental Diagnosis
The SMARCB1 NGS test screens the complete coding region of the SMARCB1 gene for pathogenic variants linked to autosomal dominant intellectual disability type 15 and associated cancer predisposition syndromes, delivering high-throughput, clinically actionable results.
اختبار SMARCB1 NGS يفحص الطفرات الجينية الممرضة في جين SMARCB1 المرتبطة بالإعاقة الذهنية النمط 15 السائدة، لتشخيص دقيق وتوجيه الرعاية الصحية.
| Feature | Our Test – SMARCB1 NGS | Closest Alternative – Sanger Sequencing |
|---|---|---|
| Methodology | Next Generation Sequencing (targeted gene panel) | Capillary Sanger sequencing (single gene) |
| Diagnostic Sensitivity | 99.9% (detects SNVs, indels, and copy number variants) | ~95% (limited to point mutations, poor CNV detection) |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011), Senior Neurologist: “Every gene tells only part of the story. A positive SMARCB1 variant should be interpreted alongside developmental history and genetic counseling; a negative result does not eliminate other causes of intellectual disability. Your child’s unique clinical journey always guides the final care plan.”
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not appropriate for asymptomatic individuals without a known family history or prior genetic counseling; it is not designed for prenatal diagnosis without explicit specialist referral.
- Exclusion: Patients under 18 years must undergo pre‑test genetic counseling in accordance with UAE CDS Law 2026 (Minors).
- Emergency Red Flags: Seek immediate medical attention if the child experiences sudden seizures, rapid loss of developmental milestones, unexplained neurological deterioration, or signs of malignancy such as a growing lump, persistent fever, or weight loss.
This information does not replace individualized clinical judgment. Always consult your treating physician.
Patient FAQ & Clinical Guidance
1. What does the SMARCB1 Genetic Test detect?
SMARCB1 NGS test accurately identifies pathogenic mutations causing autosomal dominant intellectual disability type 15. This comprehensive analysis examines the entire SMARCB1 gene sequence, enabling precise diagnosis, recurrence risk assessment, and surveillance for associated conditions such as rhabdoid tumor predisposition syndrome in at‑risk families.
يكتشف اختبار SMARCB1 NGS الطفرات الممرضة بدقة تصل إلى 99.9% والتي تسبب الإعاقة الذهنية النمط 15 السائدة، كما يساعد في تقييم مخاطر الأورام المرتبطة بالجين.
2. How is the test performed and what is the turnaround time?
A simple blood draw, DNA sample, or FTA card spot is collected by our home‑visit phlebotomist, then processed using Genetic Test selection.
يتم جمع عينة دم بسيطة أو بطاقة FTA بواسطة فريق منزلي، ثم تُعالج بتقنية التسلسل الجيني (NGS) وتظهر النتائج خلال 3–4 أسابيع، مع جلسة استشارة وراثية إلزامية قبل الفحص.
3. Is the SMARCB1 NGS covered by insurance in the UAE?
Most UAE insurers provide coverage for genetic testing when medically indicated, and our team verifies direct billing eligibility through WhatsApp before sample collection, minimizing out‑of‑pocket expenses for families. We handle pre‑authorization and submit the genetic counseling report required under UAE PDPL and Federal Decree‑Law No. 41 of 2024 (Art. 87).
تغطي معظم شركات التأمين في الإمارات الاختبارات الجينية عند وجود توصية طبية، ويقوم فريقنا بالتحقق من التغطية عبر واتساب قبل جمع العينة، وفقاً للقانون الاتحادي رقم 41 لسنة 2024.
ISO 9001:2015 Certified | Cert: INT/EGQ/2509DA/3139 | Facility License: 9834453
© 2026 — UAE Medical Diagnostics. All rights reserved. Results interpretation must be performed by a qualified healthcare professional.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians